5.71% -0.10

Pds Biotechnology Corporation (PDSB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Pds Biotechnology Corporation Azioni (PDSB) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	2.97% 10.10	10.41	10.52	12.70	9.4224
Interest Income/Expense	0.00% 1.1747	1.1748	1.0689	0.9954	0.9668
Operating Income/Loss	2.97% -10.10	-10.41	-10.52	-12.70	-9.4224
Income/Loss From Continuing Operations Before Tax	2.70% -10.60	-10.90	-10.85	-12.94	-9.6599
Income Tax Expense/Benefit, Current	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	2.70% -10.60	-10.90	-10.85	-11.53	-9.6599
Net Income/Loss	2.70% -10.60	-10.90	-10.85	-11.53	-9.6599
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	14,615% 34.82	0.2366	30.91	30.80	30.43
Diluted Average Shares	14,615% 34.82	0.2366	30.91	30.80	30.43
Basic Earnings Per Share	14.29% -0.30	-0.35	-0.35	-0.37	-0.32
Diluted Earnings Per Share	14.29% -0.30	-0.35	-0.35	-0.37	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%